Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 15 04:00PM ET
1.41
Dollar change
+0.09
Percentage change
6.82
%
Index- P/E- EPS (ttm)-2.87 Insider Own2.55% Shs Outstand5.90M Perf Week4.44%
Market Cap8.32M Forward P/E- EPS next Y-2.06 Insider Trans141.56% Shs Float5.75M Perf Month-6.62%
Income-13.23M PEG- EPS next Q-0.56 Inst Own11.56% Short Float1.66% Perf Quarter-21.45%
Sales5.51M P/S1.51 EPS this Y47.46% Inst Trans-41.99% Short Ratio1.37 Perf Half Y-19.43%
Book/sh-1.34 P/B- EPS next Y7.63% ROA-104.14% Short Interest0.10M Perf Year2.17%
Cash/sh1.43 P/C0.99 EPS next 5Y- ROE-522.50% 52W Range0.97 - 2.78 Perf YTD-19.43%
Dividend Est.- P/FCF- EPS past 5Y68.20% ROI- 52W High-49.28% Beta0.68
Dividend TTM- Quick Ratio0.50 Sales past 5Y406.45% Gross Margin86.24% 52W Low45.45% ATR (14)0.15
Dividend Ex-Date- Current Ratio0.50 EPS Y/Y TTM62.10% Oper. Margin-256.07% RSI (14)48.93 Volatility8.95% 11.59%
Employees20 Debt/Eq- Sales Y/Y TTM113.20% Profit Margin-240.15% Recom1.00 Target Price16.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q53.66% Payout- Rel Volume0.51 Prev Close1.32
Sales Surprise-24.76% EPS Surprise15.09% Sales Q/Q-31.01% EarningsAug 14 AMC Avg Volume69.54K Price1.41
SMA20-3.47% SMA50-3.04% SMA200-21.51% Trades Volume35,334 Change6.82%
Date Action Analyst Rating Change Price Target Change
Jan-25-21Initiated Ladenburg Thalmann Buy $8
Oct-16-20Initiated Maxim Group Buy $6
Oct-01-24 07:30AM
Sep-18-24 07:30AM
Sep-04-24 07:30AM
Aug-15-24 09:42AM
Aug-14-24 09:53PM
04:16PM Loading…
04:16PM
Aug-13-24 07:30AM
Aug-12-24 07:30AM
Aug-08-24 07:30AM
Jul-25-24 07:30AM
Jul-02-24 07:30AM
Jun-07-24 07:30AM
May-17-24 05:00PM
May-16-24 03:05AM
May-15-24 08:53PM
04:15PM Loading…
04:15PM
May-13-24 07:30AM
May-09-24 11:29AM
May-08-24 05:35PM
May-06-24 07:30AM
Apr-22-24 09:00AM
07:00AM
Apr-09-24 07:00AM
Mar-27-24 08:00AM
Mar-25-24 08:00AM
Mar-11-24 07:00AM
Mar-07-24 08:59AM
Mar-06-24 01:43PM
Mar-05-24 09:52PM
05:35PM
04:05PM Loading…
04:05PM
Feb-27-24 08:00AM
Dec-18-23 07:00AM
Dec-12-23 08:00AM
Nov-29-23 08:00AM
Nov-20-23 07:00AM
Nov-15-23 07:00AM
Nov-13-23 09:31AM
Nov-03-23 07:00AM
Nov-01-23 09:29AM
Oct-31-23 04:10PM
04:05PM
Oct-25-23 09:21AM
Oct-23-23 04:05PM
Oct-10-23 07:00AM
Oct-09-23 07:00AM
Sep-19-23 01:07PM
Sep-15-23 11:17AM
Sep-11-23 12:44PM
07:00AM
Sep-08-23 12:49PM
11:18AM
08:30AM
07:00AM
Sep-05-23 01:13PM
07:00AM
Aug-30-23 07:00AM
Aug-18-23 09:55AM
Aug-15-23 10:58AM
Aug-14-23 04:05PM
Aug-11-23 06:28PM
08:00AM
06:30AM
Aug-08-23 04:05PM
11:22AM
Aug-03-23 07:00AM
Jul-27-23 05:34PM
04:05PM
07:00AM
Jul-13-23 07:00AM
Jun-29-23 07:00AM
Jun-14-23 07:00AM
Jun-08-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
May-25-23 07:00AM
May-16-23 07:00AM
May-12-23 07:00AM
May-02-23 07:00AM
Apr-28-23 12:55PM
Apr-21-23 09:01AM
Apr-20-23 05:25PM
04:05PM
Apr-19-23 07:00AM
Apr-18-23 04:15PM
07:00AM
Apr-12-23 07:00AM
Mar-28-23 07:00AM
Mar-22-23 07:00AM
Feb-23-23 05:35PM
04:05PM
Feb-14-23 07:00AM
Feb-01-23 07:00AM
Jan-18-23 07:00AM
Jan-05-23 04:15PM
Nov-21-22 06:53AM
Nov-19-22 08:24AM
Nov-02-22 07:00AM
Oct-26-22 07:00AM
Oct-20-22 04:05PM
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hawkins Richard JDirectorSep 13 '24Buy1.504,0005,99615,188Sep 17 07:00 AM
Hawkins Richard JDirectorSep 12 '24Buy1.356,2858,51211,188Sep 16 07:00 AM
Petersen GregDirectorSep 11 '24Buy1.3512,50016,87548,921Sep 13 06:04 AM
Clowes HowardDirectorSep 11 '24Buy1.345,0006,68126,497Sep 13 06:04 AM
HEDRICK MARC HChief Executive OfficerSep 10 '24Buy1.238,0009,83920,425Sep 11 06:02 AM
Sims Andrew John Hugh MacIntyrChief Financial OfficerSep 10 '24Buy1.274,0985,2049,815Sep 11 06:02 AM
Sims Andrew John Hugh MacIntyrChief Financial OfficerMay 08 '24Buy2.044,90210,0005,717May 10 07:30 AM
HEDRICK MARC HChief Executive OfficerMay 08 '24Buy2.0412,25525,00012,425May 10 07:30 AM
Petersen GregDirectorMay 08 '24Buy2.0412,25525,00036,421May 10 07:30 AM
Clowes HowardDirectorMay 08 '24Buy2.049,80420,00021,497May 10 07:30 AM
Hawkins Richard JDirectorMay 08 '24Buy2.044,90210,0004,903May 10 07:30 AM
Lenk Robert PDirectorMay 08 '24Buy2.044,1678,50129,327May 10 07:30 AM
HEDRICK MARC HChief Executive OfficerNov 20 '23Sale1.962,0684,053170Dec 15 05:09 PM
Lenk Robert PDirectorNov 16 '23Buy1.951,0001,95025,160Nov 17 07:00 AM
Lenk Robert PDirectorNov 15 '23Buy1.771,0001,77024,160Nov 17 07:00 AM
Lenk Robert PDirectorNov 13 '23Buy1.434,0005,72023,160Nov 15 07:00 AM
Lenk Robert PDirectorNov 10 '23Buy1.452,0002,90019,160Nov 15 07:00 AM
Lenk Robert PDirectorNov 08 '23Buy1.655,0008,25012,961Nov 13 07:00 AM
Lenk Robert PDirectorNov 09 '23Buy1.594,1996,67617,160Nov 13 07:00 AM
Lenk Robert PDirectorNov 07 '23Buy1.646,0009,8407,961Nov 08 07:00 AM
Lenk Robert PDirectorNov 06 '23Buy1.501,3952,0921,961Nov 08 07:00 AM